April 17, 2014 8:54 AM ET

Biotechnology

Company Overview of MediciNova Inc.

Company Overview

MediciNova, Inc., a development stage biopharmaceutical company, focuses on acquiring and developing small molecule therapeutics for the treatment of serious diseases for the United States market. The company’s principal product candidates include MN-166, an ibudilast-based drug candidate, which is in Phase I and Phase II clinical trials for the treatment of drug dependence and pain; and MN-221, a ß2 -adrenergic receptor agonist that has completed Phase II clinical trials for the treatment of acute exacerbations of asthma. It also has other product candidates in the clinical development for the treatment of acute exacerbations of asthma, multiple sclerosis and other central nervous system di...

4275 Executive Square

Suite 650

San Diego, CA 92037

United States

Founded in 2000

11 Employees

Phone:

858-373-1500

Key Executives for MediciNova Inc.

Co-Founder
Age: 63
Total Annual Compensation: $504.8K
Head of Japanese Office and Vice President
Age: 45
Total Annual Compensation: $293.6K
Chief Medical Officer
Age: 47
Total Annual Compensation: $293.6K
Compensation as of Fiscal Year 2012.

MediciNova Inc. Key Developments

MediciNova Inc. Appoints Yoshio Ishizaka to its Board of Directors

MediciNova Inc. announced the appointment of Mr. Yoshio Ishizaka to its Board of Directors. Mr. Ishizaka complements the MediciNova Board with 50 years of experience in marketing and product development with Toyota Motor Corporation (TMC). His international experience includes assignments in Japan, Europe and the U.S.

Medicinova Inc Appoints Esther van den Boom as Chief Financial Officer

MediciNova Inc. announced the appointment of Esther van den Boom as Chief Financial Officer. Ms. van den Boom is owner of van den Boom & Associates, LLC, an accounting services firm that provides accounting and finance services to public and private companies. Prior to starting van den Boom & Associates, Ms. van den Boom spent nine years with Ernst & Young LLP as a Senior Manager in their audit practice where she assisted public and private biotechnology companies.

MediciNova Inc., 2013 Earnings Call, Mar 28, 2014

MediciNova Inc., 2013 Earnings Call, Mar 28, 2014

Similar Private Companies By Industry

Company Name Region
ZymoGenetics Inc. United States
Dynal Biotech LLC United States
KannaLife Sciences, Inc. United States
ImmuneWorks, Inc. United States
NeuroVir Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 9, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MediciNova Inc., please visit www.medicinova.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.